Nikhil Singh

Employment

• Regeneron (United States) Medical Director
  2024 - Present
• Regeneron (United States) Medical Director
  2023 - 2024
• Regeneron Pharmaceuticals Inc Associate Medical Director, Early Clinical Development & Experimental Sciences
  2020 - 2022
• Yale University Instructor of Medicine and Postdoctoral Fellow
  2019 - 2020

Education

• Cornell University B.A.
• University of Pennsylvania MD
• University of Pennsylvania PhD

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• A TMPRSS6-inhibiting mAb improves disease in a β-thalassemia mouse model and reduces iron in healthy humans
  JCI Insight 2025 DOI: 10.1172/jci.insight.191813
  +Save
• Development of a 2-dimensional atlas of the human kidney with imaging mass cytometry.
  JCI insight 2019 DOI: 10.1172/jci.insight.129477
  +Save
• Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis.
  JCI insight 2019 DOI: 10.1172/jci.insight.127456
  +Save
• Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression.
  Developmental biology 2013 DOI: 10.1016/j.ydbio.2013.03.008
  +Save
• Histone deacetylase 3 regulates smooth muscle differentiation in neural crest cells and development of the cardiac outflow tract.
  Circulation research 2011 DOI: 10.1161/CIRCRESAHA.111.255067
  +Save
• Diet-induced lethality due to deletion of the Hdac3 gene in heart and skeletal muscle.
  The Journal of biological chemistry 2011 DOI: 10.1074/jbc.M111.277707
  +Save
• The effect of genetic background on the function of Saccharomyces cerevisiae mlh1 alleles that correspond to HNPCC missense mutations.
  Human molecular genetics 2007 DOI: 10.1093/hmg/ddl479
  +Save